← Leaderboards
Bon Q Trinh
Beth Israel Deaconess Medical Center
$986,469
Attributed
$986,469
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $415.3K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$986,469 · 2
By mechanism
K01$571,210 · 1
R21$415,259 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Dong-Er Zhang$30,254,830
- Daniel G Tenen$44,879,800
- Vassiliki A Boussiotis$19,288,605
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsAcute Myelocytic LeukemiaInsightMyeloid CellsSamplingUntranslated RnaGene Expression RegulationGrantMalignant NeoplasmsMouse ModelEnhancersQ22)Transcription FactorTumor Suppressor ProteinsCancer Therapy21)(Q22Genetic TranscriptionCell Differentiation ProcessChromatin StructureChromatinMediatingMolecularBone Marrow TransplantationBone Marrow
Grant awards (7)
The role of long noncoding RNAs in acute myeloid leukemia$415,259
R21 · FY2024 · CA · contact PI
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis$73,632
K01 · FY2021 · CA · contact PI
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis$40,610
K01 · FY2021 · CA · contact PI
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis$114,242
K01 · FY2020 · CA · contact PI
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis$114,242
K01 · FY2019 · CA · contact PI
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis$114,242
K01 · FY2018 · CA · contact PI
Enhancer RNA-mediated Tumor Suppressor Gene Expression in Normal and Malignant Hematopoiesis$114,242
K01 · FY2017 · CA · contact PI